55
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Oral administration of glycine in the prevention of restenosis after coronary angioplasty. A double blind placebo controlled randomized feasibility trial evaluating safety and efficacy of glycine in the prevention of restenosis after angioplasty

, , , , , & show all
Pages 58-64 | Accepted 17 Feb 2006, Published online: 26 Aug 2009

References

  • Gravanis M. B., Roubin G. S. Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis. Hum Pathol 1989; 20: 477–86
  • Serruys P. W., de Jaegere, Kiemeney F., et al. A comparison of balloon‐expandable stent implantation with balloon angioplasty in patients with coronary artery disease (Benestent I ). N Eng J Med 1994; 331: 489–95
  • Fischman D. L., Leon M. B., Baim D. S., et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease (STRESS). N Eng J Med 1994; 331: 496–501
  • Azar A. J., Detre K., Goldberg S., Kiemeneij F., Leon M. B., Serruys P. W., on behalf of the Benestent and stent Restenosis Study. A meta‐analysis on the clinical and angiographic outcomes of stents versus PTCA in the different coronary vessel sizes in the Benestent‐1 and Stress‐1/2 trials. Circulation 1995; 92: 1–475, Supplement I, abstract
  • Topol E. J., Califf R. M., Weisman H. F., Willerson J. T., et al. for the EPIC Investigators. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa intergrin for reduction of clinical restenosis: results at 6 months. Lancet 1994; 343: 881–6
  • Serruys P. W., Foley D. P., Hofling B., Simon R., , on behalf of the EUROCARE study group, et al. Carvedilol for prevention of restenosis after directional coronary atherectomy. Circulation 2000; 101: 1512–8
  • Rodes J., Cote G., Lesperance J., Tardif J. C., et al. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation 1998; 97: 429–36
  • Kalinowski M., Alfke H., Bergen S., Wagner H. J., et al. Comparative trial of local pharmacotherapy with L‐arginine, r‐hirudin and molsidomine to reduce restenosis after balloon angioplasty of restenotic rabbit iliac arteries. Radiology 2001; 219: 716–23
  • Riessen R., Isner J. M. Prospects for site‐specific delivery of pharmacological and molecular therapies. J Am Coll Cardiol 1994; 23: 1234–44
  • Kay I. P., Wardeh A. J., Kozuma K., Serruys P. W., et al. radioactive stents delay but do not prevent in stent neointimal hyperplasia. Circulation 2001; 103: 14–7
  • Waksman R., Bhargava B., White L., Kent K., et al. Intracoronary B‐radiation therapy inhibits recurrence of in‐stent restenosis. Circulation 2001; 101: 1895–8
  • Morice M. C., Serruys P. W., Sousa J. E., et al. A randomised comparison of a sirolimus‐eluting stent with a standard stent for coronary revascularization. N Eng J Med 2002; 346: 1773–80
  • Grube E., Siber M. S., Hauptmann K. E., et al. Prospective randomised, double blind comparison of NIRx stents coated with paclitaxel in a polymer carrier in de‐novo coronary lesions compared with uncoated controls. Circulation 2001; 104: II–463
  • Tanabe K., Serruys P. W., Grube E., et al. In‐stent restenosis treated with stent‐based delivery of paclitaxel incorporated in a slow‐release polymere formulation. Circulation 2003; 107: 559–64
  • Tourneau T., Belle v. E., Corseaux D., Bertrand M., et al. Role of nitric oxide in re‐stenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodelling. J Am Coll Cardiol 1999; 33: 876–82
  • Lee J. S., Jacob H. J., Roberts J. D., Zapol W. M., Bloch K. D. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon induced arterial injury. Circulation Research 1996; 78: 337–42
  • Quyyumi A., Dakak N., Mulcahy D., Panza J. A., et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 1997; 29: 308–17
  • Janero D., Ewing J. F. Nitric oxide and post angioplasty restenosis: pathological correlates and therapeutic potential. Free Radical Biology & Medicine 2000; 29: 1199–221
  • Zhong Z., Arteel G., Conner H., Thurman R. G., et al. Cyclosporin a increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 1998; 275: F595–604
  • Spittler A., Reissner C., Manhart N., et al. Glycine modulates cytokine production of human blood cell monocytes. Clin Nutr 1997; 16: 19, Supplement 2, abstract
  • Zhong Z., Jones S., Thurman R. G., et al. Glycine minimizes reperfusion injury in the rat. Am J Physiol 1996; 270: g332–38
  • Moreno P. R., Bernardi V. H., Lopez‐Cuellar J., et al. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996; 94: 3098–102
  • Niebauer J., Schwarzacher S. P., Hayase M., Yeung A. C., et al. Local L‐arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis. Circulation 1999; 100: 1830–5
  • Quyyumi A., Dakak N., Diodati J. G., Cannon III R. O., et al. effect of L‐arginine on human coronary endothelium dependent and physiologic vasodilatation. J Am Coll Cardiol 1997; 30: 1220–7
  • Adams M., Forsyth C. J., Jessup W., Robinson J., Celermajer D. S. Oral L‐arginine inhibits platelet aggregation but does not enhance endothelium dependent dilation in healthy young men. J Am Coll Cardiol 1995; 26: 1054–61
  • Kiemeneij F., Laarman G. J., Slagboom T., Wieken van der. Outpatient coronary stent implantation. J Am Coll Cardiol 1997; 29: 323–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.